US Patent Issued to EPICENTRX on June 4 for "Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter" (California Inventors)

  • Christopher Larson

Press/Media

Period5 Jun 2024

Media coverage

1

Media coverage

  • TitleUS Patent Issued to EPICENTRX on June 4 for "Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter" (California Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date5/06/24
    PersonsChristopher Larson
View all 1
View less